Increased Blood Pressure During Speech Therapy in Patients with Language Disorder.
Tetsuo Tani(Keio University), Yoshiro Sugai, Yasuhide Hasegawa(Speech Pathology Australia), Yuki Saito(Speech Pathology Australia), Hironosuke Sakamoto(Gunma University), Hiromi Nakajima(Speech Pathology Australia)
Cited by 0
Related Papers
<i>In vitro</i> modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant <i>EGFR</i> mutants in non-small-cell lung cancer
|Oncotarget|2015|159
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
|Cancer Cell|2022|101
<i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
|Cancer Discovery|2024|98
Activation of Tumor-Cell STING Primes NK-Cell Therapy
|Cancer Immunology Research|2022|88
Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung Cancer
|Molecular Cancer Research|2016|73